Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

May 14, 2010

30071_dirs_2010-05-14_e24ca90d-0465-416c-851a-ce5ca46cfab9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-05-12

Reporting Person: Farrell Michael J. (Sr. VP Sleep SBU)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-12 ResMed Common Stock M 15000 $38.50 Acquired 15435.732 Direct
2010-05-12 ResMed Common Stock S 15000 $68.50 Disposed 435.732 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-05-12 ResMed Common Stock Options $38.50 M 15000 Disposed 2016-02-03 ResMed Common Stock (15000) Direct

Footnotes

F1: Represents first date options became exercisable. Options vest 1/4 annually.

F2: Includes 33.019 shares purchased on April 30, 2010, pursuant to ResMed's Employee Stock Purchase Plan.